Clinical Research Directory
Browse clinical research sites, groups, and studies.
North American Prodromal Synucleinopathy Consortium Stage 2
Sponsor: Washington University School of Medicine
Summary
This study will enroll participants with idiopathic REM sleep behavior disorder (RBD) and healthy controls for the purpose of preparing for a clinical trial of neuroprotective treatments against synucleinopathies.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
500
Start Date
2022-08-12
Completion Date
2025-05-01
Last Updated
2024-11-06
Healthy Volunteers
Yes
Conditions
Locations (9)
University of California Los Angeles
Los Angeles, California, United States
Stanford University
Redwood City, California, United States
Emory University
Atlanta, Georgia, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
University of Minnesota
Minneapolis, Minnesota, United States
Mayo Clinic Rochester
Rochester, Minnesota, United States
Washington University School of Medicine
St Louis, Missouri, United States
Oregon Health Sciences University
Portland, Oregon, United States
McGill University Health Centre Research Institute
Montreal, Quebec, Canada